Effects of Probiotics in Adults with Gastroenteritis: A Systematic Review and Meta-Analysis of Clinical Trials
Author:
Mitra Amal K.1ORCID, Asala Adetoun F.12, Malone Shelia1ORCID, Mridha Malay Kanti3
Affiliation:
1. Department of Epidemiology and Biostatistics, College of Health Sciences, Jackson State University, Jackson, MS 39213, USA 2. Office of Preventive Heath, Mississippi State Department of Health, Ridgeland, MS 39157, USA 3. Brac James P. Grant School of Public Health, Center for Non-Communicable Disease and Nutrition, Brac University, Dhaka 1213, Bangladesh
Abstract
Probiotics have been widely used in gastroenteritis due to acute and chronic illnesses. However, evidence supporting the effectiveness of probiotics in different health conditions is inconclusive and conflicting. The aim of this study was to review the existing literature on the effects of probiotics on gastroenteritis among adults. Only original articles on clinical trials that demonstrated the effects of probiotics in adults with gastroenteritis were used for this analysis. Multiple databases, such as PubMed, Google Scholar, MEDLINE and Scopus databases, were searched for the data. The study followed standard procedures for data extraction using a PRISMA flow chart. A quality appraisal of the selected studies was conducted using CADIMA. Finally, a meta-analysis was performed. Thirty-five articles met the selection criteria; of them, probiotics were found effective in the treatment and/or prevention of chronic inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease in 17 (49%), and the treatment of pouchitis in 4 (11.4%), antibiotic-induced diarrhea in 3 (8.6%), Helicobacter pylori infection in 2 (5.7%) and diverticulitis in 1 (2.9%), while the remaining 7 (20%) were ineffective, and 1 study’s results were inconclusive. The meta-analysis did not demonstrate any significant protective effects of probiotics. Having a τ2 value of zero and I2 of 6%, the studies were homogeneous and had minimum variances. Further studies are suggested to evaluate the beneficial effects of probiotics in IBDs and other chronic bowel diseases.
Reference65 articles.
1. Bartsch, S.M., Lopman, B.A., Ozawa, S., Hall, A.J., and Lee, B.Y. (2016). Global economic burden of norovirus gastroenteritis. PLoS ONE, 11. 2. A systematic review and meta-analysis of the prevalence of norovirus in cases of gastroenteritis in developing countries;Nguyen;Medicine,2017 3. Acute gastroenteritis;Graves;Prim. Care Clin. Off. Pract.,2013 4. Jagai, J.S., Smith, G.S., Schmid, J.E., and Wade, T.J. (2014). Trends in gastroenteritis-associated mortality in the United States, 1985–2005: Variations by ICD-9 and ICD-10 codes. BMC Gastroenterol., 14. 5. Magill, A.J., Ryan, E.T., Hill, D.R., and Solomon, T. (2013). Hunter’s Tropical Medicine and Emerging Infectious Disease, Saunders Elsevier Inc.. [9th ed.].
|
|